You are currently on the new version of our website. Access the old version .

5,783 Results Found

  • Guidelines
  • Open Access
7 Citations
4,704 Views
21 Pages

Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials

  • Edward Laane,
  • Sam Salek,
  • Esther Natalie Oliva,
  • Christine Bennink,
  • Solène Clavreul,
  • Paul G Richardson,
  • Christof Scheid,
  • Katja Weisel and
  • Tatyana Ionova

8 December 2023

In the era of personalized medicine there is an increasing need for the assessment of patient-reported outcomes (PROs) to become a standard of patient care. Patient-reported outcome measures (PROM) are important in assessing significant and meaningfu...

  • Review
  • Open Access
2,057 Views
26 Pages

Exploring Demographic Representation and Reporting in Lung Cancer Clinical Trials with Canadian Sites from 2013 to 2023

  • Sierra A. Land,
  • Rajvi J. Wani,
  • Naila Inam,
  • Hilary J. G. Hewitt,
  • Paulo Eduardo Muniz Covizzi and
  • Tarah Sheculski Rivard

17 September 2024

This review evaluates the reporting of demographic characteristics and the diversity of participants of phase III lung cancer clinical trials with Canadian research sites. A literature search was conducted using the ClinicalTrials.gov registry to ide...

  • Systematic Review
  • Open Access
11 Citations
3,224 Views
17 Pages

The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review

  • Sam Salek,
  • Tatiana Ionova,
  • Esther Natalie Oliva,
  • Marike Andreas,
  • Nicole Skoetz,
  • Nina Kreuzberger and
  • Edward Laane

6 December 2022

Background: Patient-reported outcomes (PROs) are becoming increasingly important in supporting clinical outcomes in clinical trials. In multiple myeloma (MM), PRO measurement is useful to reveal how treatment affects physical, psychosocial, and funct...

  • Review
  • Open Access
4 Citations
1,955 Views
11 Pages

Do Patient-Reported Outcome Measures (PROMs) Used Within Radiotherapy Clinical Trials Reflect the Impact of Treatment?

  • Danielle Fairweather,
  • Rachel M. Taylor,
  • Laura Allington,
  • Nazima Haji,
  • Naomi Fersht,
  • Yen-Ching Chang and
  • Rita Simões

14 November 2024

This is the first article that investigates whether the patient-reported outcome measures (PROMs) used in clinical trials effectively capture the specific side-effects of radiotherapy and proton beam therapy (PBT) and provides context for researchers...

  • Article
  • Open Access
4 Citations
2,713 Views
18 Pages

Self-Reporting Technique-Based Clinical-Trial Service Platform for Real-Time Arrhythmia Detection

  • Heejin Kim,
  • Ki Young Huh,
  • Meihua Piao,
  • Hyeongju Ryu,
  • Wooseok Yang,
  • SeungHwan Lee and
  • Kyung Hwan Kim

30 April 2022

The analysis of the electrocardiogram (ECG) is critical for the diagnosis of arrhythmias. Recent advances in information and communications technology (ICT) have led to the development of wearable ECG devices and arrhythmia-detection algorithms. This...

  • Article
  • Open Access
518 Views
17 Pages

The Outcome and Impact of Academic Cancer Clinical Trials with Participation from Canadian Sites (2015–2024)

  • Rebecca Y. Xu,
  • Diana Kato,
  • Victoria Percival,
  • James Schoales,
  • Stephen Sundquist,
  • Raisa Chowdhury,
  • Gregory R. Pond and
  • Janet E. Dancey

16 December 2025

Background/Objectives: Academically sponsored cancer clinical trials (ACCTs) are essential for advancing patient-centered care, particularly in areas underserved by commercial research. The Canadian Cancer Clinical Trials Network (3CTN) was establish...

  • Article
  • Open Access
2 Citations
5,030 Views
11 Pages

The Current Landscape of Clinical Trials

  • Geeta Joshi,
  • Tara K. Bhandari,
  • Pushkar Joshi,
  • Smriti Bhandari,
  • Shalini Reddy Araveeti,
  • Aditi Jain,
  • Subash Khadka,
  • Shaun Trecarten,
  • Ahmad Abdelaziz and
  • Mukund Bhandari
  • + 1 author

7 April 2025

Background/Objectives: Clinical trials are essential in the development of new medical treatments, offering crucial data on their safety and effectiveness. Methods: This study provides a comprehensive analysis of clinical trials registered on Clinica...

  • Article
  • Open Access
500 Views
15 Pages

3 December 2025

Background/Objectives: The quality of trial data reporting within the field of anesthesiology has, to date, been insufficiently examined. This study aims to investigate the consistency of reporting for WHO Data Set Items, trial outcomes, and adverse...

  • Article
  • Open Access
3 Citations
5,226 Views
7 Pages

Background: Psychometric instruments such as the Repeated Battery for the Assessment of Neuropsychological Status (RBANS) are commonly used under conditions for which they were not developed or validated. They may then generate troublesome data that...

  • Perspective
  • Open Access
2,814 Views
9 Pages

27 June 2023

Polypharmacy, the use of multiple and potentially inappropriate medications, is an increasing problem among older adults. The global polypharmacy prevalence is 34.6% in patients with COVID-19, and polypharmacy in COVID-19 increases with age. The pres...

  • Review
  • Open Access
567 Views
27 Pages

30 December 2025

Bacteriophages, viruses that target bacteria, offer a promising alternative to antibiotics in the face of escalating bacterial resistance. Despite their discovery over a century ago, their widespread adoption has been impeded by regulatory challenges...

  • Review
  • Open Access
26 Citations
3,215 Views
13 Pages

15 November 2023

Objective: Tinnitus assessment and outcome measurement are complex, as tinnitus is a purely subjective phenomenon. Instruments used for the outcome measurement of tinnitus in the context of clinical trials include self-report questionnaires, visual a...

  • Article
  • Open Access
15 Citations
6,861 Views
11 Pages

Background: Surveys of acupuncture practitioners worldwide have shown an increase in the use of acupuncture to treat women’s health conditions over the last ten years. Published studies have explored the effectiveness of acupuncture for various...

  • Feature Paper
  • Review
  • Open Access
5 Citations
4,371 Views
15 Pages

15 July 2019

Background and objectives: Informed decision-making requires the ability to identify and integrate high-quality scientific evidence in daily practice. We aimed to assess whether randomized controlled trials (RCTs) on endometriosis therapy follow meth...

  • Article
  • Open Access
333 Views
10 Pages

Quality-of-Life Comparison of Three Different Breath-Hold Techniques for Left-Sided Breast Radiation

  • Caroline Hircock,
  • Adrian Wai Chan,
  • Anh Hoang,
  • Hanbo Chen,
  • Merrylee McGuffin,
  • Danny Vesprini,
  • Liying Zhang,
  • Matt Wronski and
  • Irene Karam

5 December 2025

Purpose: This study aimed to compare QoL outcomes among patients undergoing active breathing control (ABC), voluntary deep inspiration breath hold (vDIBH), and surface-guided radiation therapy (SGRT). Methods: This was a non-randomized, three-arm cli...

  • Article
  • Open Access
1 Citations
7,773 Views
22 Pages

15 August 2025

Retrieval-Augmented Generation (RAG) combined with Large Language Models (LLMs) introduces a new paradigm for clinical-trial data analysis that is both real-time and knowledge-traceable. This study targets a multi-site, real-world data environment. I...

  • Article
  • Open Access
3 Citations
2,733 Views
12 Pages

COVID-19-Induced Acute Respiratory Distress Syndrome Treated with Hyperbaric Oxygen: Interim Safety Report from a Randomized Clinical Trial (COVID-19-HBO)

  • Anders Kjellberg,
  • Johan Douglas,
  • Adrian Hassler,
  • Sarah Al-Ezerjawi,
  • Emil Boström,
  • Lina Abdel-Halim,
  • Lovisa Liwenborg,
  • Eric Hetting,
  • Anna Dora Jonasdottir Njåstad and
  • Peter Lindholm
  • + 3 authors

24 July 2023

Background: A few prospective trials and case series have suggested that hyperbaric oxygen therapy (HBOT) may be efficacious for the treatment of severe COVID-19, but safety is a concern for critically ill patients. We present an interim analysis of...

  • Article
  • Open Access
2 Citations
1,967 Views
12 Pages

23 November 2023

Despite the motivation of oncology patients to take part in clinical trials, only a minority of them are enrolled in clinical trials. Implementation of new practical procedures can become a barrier that withholds patients from participating in clinic...

  • Review
  • Open Access
1 Citations
3,212 Views
11 Pages

29 January 2024

Gallbladder cancer is a devastating disease with a 5-year survival of only 18%. The majority of gallbladder cancers are discovered incidentally in patients undergoing cholecystectomy. During non-oncologic laparoscopic cholecystectomy for gallbladder...

  • Brief Report
  • Open Access
6 Citations
2,929 Views
8 Pages

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

  • Timothy A. Lin,
  • Clifton David Fuller,
  • Vivek Verma,
  • Walker Mainwaring,
  • Andres F. Espinoza,
  • Austin B. Miller,
  • Amit Jethanandani,
  • Dario Pasalic,
  • Prajnan Das and
  • Ethan B. Ludmir
  • + 5 authors

16 September 2020

The pace of clinical trial data generation and publication is an area of interest within clinical oncology; however, little is known about the dynamics and covariates of time to reporting (TTR) of trial results. To assess these, ClinicalTrials.gov wa...

  • Perspective
  • Open Access
25 Citations
131,189 Views
9 Pages

26 February 2021

Relative risk reduction and absolute risk reduction measures in the evaluation of clinical trial data are poorly understood by health professionals and the public. The absence of reported absolute risk reduction in COVID-19 vaccine clinical trials ca...

  • Article
  • Open Access
16 Citations
3,184 Views
10 Pages

Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting

  • Thejus Jayakrishnan,
  • Sonikpreet Aulakh,
  • Mizba Baksh,
  • Kianna Nguyen,
  • Meghna Ailawadhi,
  • Ayesha Samreen,
  • Ricardo Parrondo,
  • Taimur Sher,
  • Vivek Roy and
  • Sikander Ailawadhi
  • + 3 authors

18 November 2021

Background: Concern exists that the clinical trial populations differ from respective cancer populations in terms of their age distribution affecting the generalizability of the results, especially in underrepresented minorities. We hypothesized that...

  • Systematic Review
  • Open Access
43 Citations
7,830 Views
16 Pages

15 November 2021

Sex and gender have implications for COVID-19 vaccine efficacy and adverse effects from the vaccine. As vaccination is one of the key responses to the COVID-19 pandemic, it is vital that sex and gender differences be acknowledged, measured, and analy...

  • Article
  • Open Access
2,107 Views
11 Pages

Objectives: The aim of our current study was to analyze whether the use of important measures of methodological quality and reporting of randomized clinical trials published in the field of cardiovascular disease research haschanged over time. A furt...

  • Study Protocol
  • Open Access
1 Citations
2,246 Views
10 Pages

Study Protocol on Social Return on Investment (SROI) Project of the Surgical Waiting List Management System

  • José Luis González Muñoz,
  • Nuria García-Agua Soler and
  • Antonio J. García Ruiz

In Andalusia, the right to maximum waiting times for healthcare clashes with the available supply, leading to an increase in demand in the form of waiting lists. To address this situation, the activity of private centers has been created for certain...

  • Review
  • Open Access
83 Citations
19,982 Views
42 Pages

Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis

  • Mafalda Bacalhau,
  • Mariana Camargo,
  • Grace A. V. Magalhães-Ghiotto,
  • Sybelle Drumond,
  • Carlos Henrique M. Castelletti and
  • Miquéias Lopes-Pacheco

Cystic fibrosis (CF) is a potentially fatal monogenic disease that causes a progressive multisystemic pathology. Over the last decade, the introduction of CF transmembrane conductance regulator (CFTR) modulator drugs into clinical practice has profou...

  • Review
  • Open Access
11 Citations
4,191 Views
15 Pages

Artificial Intelligence Reporting Guidelines’ Adherence in Nephrology for Improved Research and Clinical Outcomes

  • Amankeldi A. Salybekov,
  • Markus Wolfien,
  • Waldemar Hahn,
  • Sumi Hidaka and
  • Shuzo Kobayashi

The use of artificial intelligence (AI) in healthcare is transforming a number of medical fields, including nephrology. The integration of various AI techniques in nephrology facilitates the prediction of the early detection, diagnosis, prognosis, an...

  • Article
  • Open Access
24 Citations
5,743 Views
16 Pages

The Value of Case Reports in Systematic Reviews from Rare Diseases. The Example of Enzyme Replacement Therapy (ERT) in Patients with Mucopolysaccharidosis Type II (MPS-II)

  • Miguel Sampayo-Cordero,
  • Bernat Miguel-Huguet,
  • Andrea Malfettone,
  • José Manuel Pérez-García,
  • Antonio Llombart-Cussac,
  • Javier Cortés,
  • Almudena Pardo and
  • Jordi Pérez-López

Background: Case reports are usually excluded from systematic reviews. Patients with rare diseases are more dependent on novel individualized strategies than patients with common diseases. We reviewed and summarized the novelties reported by case rep...

  • Review
  • Open Access
9 Citations
4,775 Views
14 Pages

25 December 2021

Background: A new type of foods with a health claims notification system, the Foods with Function Claims (FFC), was introduced in Japan in April 2015. This cross-sectional study sought to clarify compliance of clinical trial protocols reported as the...

  • Meeting Report
  • Open Access
3 Citations
887 Views
6 Pages

Report on a Delphi Process and Workshop to Improve Accrual to Cancer Clinical Trials

  • J.A.H. Bell,
  • L.G. Balneaves,
  • M.T. Kelly and
  • H. Richardson

1 April 2016

Cancer clinical trials (ccts) are essential for furthering knowledge and developing effective interventions to improve the lives of people living with cancer in Canada. Randomized controlled trials are particularly important for developing evidence-b...

  • Review
  • Open Access
17 Citations
12,705 Views
38 Pages

Minimal Clinically Important Difference of Scales Reported in Stroke Trials: A Review

  • Biswamohan Mishra,
  • Pachipala Sudheer,
  • Ayush Agarwal,
  • Nilima Nilima,
  • Madakasira Vasantha Padma Srivastava and
  • Venugopalan Y. Vishnu

13 January 2024

There is a growing awareness of the significance of using minimum clinically important differences (MCIDs) in stroke research. An MCID is the smallest change in an outcome measure that is considered clinically meaningful. This review is the first to...

  • Article
  • Open Access
3 Citations
462 Views
10 Pages

A Tolerability Burden Index in Schizophrenia: Incorporating Patient Perspective in Clinical Trial Adverse Event Reporting

  • Clément François,
  • Alice Guiraud-Diawara,
  • Christophe Lançon,
  • Pierre Michel Llorca,
  • Ann Hartry,
  • Lene Hammer-Helmich,
  • Djamel A. Zighed,
  • Adrian Tanasescu and
  • Mondher Toumi

Background: Adverse event (AE) reporting in clinical trials does not fully capture the patient-level perspective and comparing tolerability across treatments or among studies is difficult. Objective: This study was designed to develop a treatment tol...

  • Review
  • Open Access
26 Citations
10,259 Views
19 Pages

Assessment of Pain in Osteoarthritis of the Knee

  • Aricia Jieqi Thirumaran,
  • Leticia Alle Deveza,
  • Inoshi Atukorala and
  • David J. Hunter

14 July 2023

Knee osteoarthritis (KOA) pain is a subjective and personal experience, making it challenging to characterise patients’ experiences and assess their pain. In addition, there is no global standard for the assessment of pain in KOA. Therefore, th...

  • Conference Report
  • Open Access
57 Citations
15,806 Views
13 Pages

Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

  • Lori E. Lowes,
  • Scott V. Bratman,
  • Ryan Dittamore,
  • Susan Done,
  • Shana O. Kelley,
  • Sabine Mai,
  • Ryan D. Morin,
  • Alexander W. Wyatt and
  • Alison L. Allan

8 September 2016

Despite the identification of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) as potential blood-based biomarkers capable of providing prognostic and predictive information in cancer, they have not been incorporated into routine clinical pra...

  • Communication
  • Open Access
2 Citations
1,410 Views
7 Pages

Understanding the Role of Patient-Reported Outcomes for Decision-Making in Early-Phase Dose-Finding Clinical Trials

  • Richard Brown,
  • Nolan A. Wages,
  • Li Liu,
  • Arnethea L. Sutton and
  • Andrew S. Poklepovic

In early-phase dose-finding clinical trials, integrating patient-reported outcomes (PROs) is essential for enhancing patient-centered decision-making. This short communication advocates for several key practices to achieve such integration. Firstly,...

  • Article
  • Open Access
4 Citations
3,939 Views
12 Pages

8 February 2023

Our primary objective was to determine the proportion of trials that report the number of patients assessed for eligibility before randomization. We performed the systematic retrieval and analysis of all phase II, III, and IV RCTs published between 2...

  • Review
  • Open Access
22 Citations
4,372 Views
14 Pages

Customized Root-Analogue Implants: A Review on Outcomes from Clinical Trials and Case Reports

  • Telma Dantas,
  • Sara Madeira,
  • Michael Gasik,
  • Paula Vaz and
  • Filipe Silva

29 April 2021

(1) It is estimated that 10% of the world’s population will need a dental implant in their lifetime. Despite all the advances in the comprehension of dental implant designs, materials and techniques, traditional implants still have many limitations....

  • Systematic Review
  • Open Access
194 Views
17 Pages

Quality of Life Measures in Advanced Endometrial Cancer: A Systematic Review of Reporting Practices in Phase III Clinical Trials

  • Justine Himpe,
  • Marjolein Orije,
  • Emiel A. De Jaeghere,
  • Katrien Vandecasteele and
  • Hannelore Denys

14 January 2026

Background: Advanced endometrial cancer is associated with poor survival. With the advent of molecular classification and novel systemic therapies—including immunotherapy and targeted agents—treatment regimens have become increasingly com...

  • Systematic Review
  • Open Access
7 Citations
2,395 Views
8 Pages

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review

  • Mariachiara Santorsola,
  • Vincenzo Di Lauro,
  • Guglielmo Nasti,
  • Michele Caraglia,
  • Maurizio Capuozzo,
  • Francesco Perri,
  • Marco Cascella,
  • Gabriella Misso and
  • Alessandro Ottaiano

3 July 2022

Background: Randomised phase III clinical trials represent a methodological milestone to select effective drugs against metastatic cancers. In this context, and particularly in the efficacy assessment of biologic drugs, the initial metastatic tumour...

  • Article
  • Open Access
9 Citations
3,394 Views
10 Pages

The Spring Distraction System for Growth-Friendly Surgical Treatment of Early Onset Scoliosis: A Preliminary Report on Clinical Results and Safety after Design Iterations in a Prospective Clinical Trial

  • Casper S. Tabeling,
  • Justin V. C. Lemans,
  • Anouk Top,
  • E. Pauline Scholten,
  • Hilde W. Stempels,
  • Tom P. C. Schlösser,
  • Keita Ito,
  • René M. Castelein and
  • Moyo C. Kruyt

28 June 2022

Background: The Spring Distraction System (SDS) is a dynamic growth-friendly implant to treat early onset scoliosis (EOS). Previous SDS studies showed promising results in terms of curve correction and complication profile. Nevertheless, complication...

  • Review
  • Open Access
20 Citations
5,358 Views
17 Pages

23 August 2021

Patient-reported outcome (PRO) instruments are widely used to assess quality of life in Systemic Lupus Erythematosus (SLE) research, and there is growing evidence for their use in clinical care. In this review, we evaluate the current evidence for th...

  • Perspective
  • Open Access
34 Citations
11,438 Views
24 Pages

Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)

  • Julia Chisholm,
  • Henry Mandeville,
  • Madeleine Adams,
  • Veronique Minard-Collin,
  • Timothy Rogers,
  • Anna Kelsey,
  • Janet Shipley,
  • Rick R. van Rijn,
  • Isabelle de Vries and
  • Meriel Jenney
  • + 17 authors

29 February 2024

The Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) clinical trial is an overarching, multinational study for children and adults with rhabdomyosarcoma (RMS). The trial, developed by the European Soft Tissue Sarcoma Study Group (EpSSG), incorporate...

  • Communication
  • Open Access
7 Citations
3,094 Views
11 Pages

Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study

  • Huaizhi Geng,
  • Zhongxing Liao,
  • Quynh-Nhu Nguyen,
  • Abigail T. Berman,
  • Clifford Robinson,
  • Abraham Wu,
  • Romaine Charles Nichols Jr,
  • Henning Willers,
  • Nasiruddin Mohammed and
  • Ying Xiao
  • + 1 author

5 February 2023

The outcome of the patient and the success of clinical trials involving RT is dependent on the quality assurance of the RT plans. Knowledge-based Planning (KBP) models using data from a library of high-quality plans have been utilized in radiotherapy...

  • Article
  • Open Access
3,525 Views
11 Pages

Immunogenicity Persistence of Different Immunization Regimens of Rabies Vaccine in the 10–60 Years Age Group: A Follow-Up Report Based on Phase III Clinical Trial

  • Yunpeng Wang,
  • Zhiang Wu,
  • Jia Li,
  • Shouchun Cao,
  • Leitai Shi,
  • Danhua Zhao,
  • Zhaojun Mo,
  • Haiyan Liang and
  • Xiaohong Wu

24 October 2024

Objectives: This study evaluated the 12-month persistence of rabies virus-neutralizing antibody (RVNA) following different immunization regimens of freeze-dried human rabies vaccine (Vero cells) in individuals aged 10–60 years within the Chines...

  • Systematic Review
  • Open Access
9 Citations
2,834 Views
20 Pages

23 June 2021

Bone metastases, occurring in 30–60% of patients with non-small cell lung cancer (NSCLC), are associated with decreased survival, cancer-induced bone pain, and skeletal-related events (SREs). Those with an activating epidermal growth factor mutation...

  • Review
  • Open Access
1 Citations
2,776 Views
14 Pages

17 August 2024

Background: The Foods with Function Claim was introduced in Japan in April 2015 to make more products available that are labeled with health functions. A product’s functionality of function claims must be explained by the scientific evidence pr...

  • Systematic Review
  • Open Access
1 Citations
2,199 Views
21 Pages

Quality of Surgical Outcome Reporting in Randomised Clinical Trials of Multimodal Rectal Cancer Treatment: A Systematic Review

  • Joanna Janczak,
  • Kristjan Ukegjini,
  • Stephan Bischofberger,
  • Matthias Turina,
  • Philip C. Müller and
  • Thomas Steffen

20 December 2023

Introduction: Randomised controlled trials (RCTs) continue to provide the best evidence for treatment options, but the quality of reporting in RCTs and the completeness rate of reporting of surgical outcomes and complication data vary widely. The aim...

  • Article
  • Open Access
394 Views
15 Pages

Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial

  • Leandra Durham,
  • Robert A. Oster,
  • Matthew Ithurburn,
  • Chelsi Reynolds,
  • James O. Hill and
  • Daniel L. Smith

10 January 2026

Background: Chronic pain, which affects over 50 million adults in the United States, has stimulated growing interest in natural and nutrition-based remedies as adjuncts to pharmacologic therapies. Evidence suggests that turmeric and related extracts...

  • Article
  • Open Access
32 Citations
10,852 Views
16 Pages

Prebiotic Galacto-Oligosaccharides Impact Stool Frequency and Fecal Microbiota in Self-Reported Constipated Adults: A Randomized Clinical Trial

  • Marieke H. Schoemaker,
  • Jeske H. J. Hageman,
  • Dominique ten Haaf,
  • Anita Hartog,
  • Petra A. M. J. Scholtens,
  • Jos Boekhorst,
  • Arjen Nauta and
  • Rolf Bos

12 January 2022

Constipation is a major issue for 10–20% of the global population. In a double-blind randomized placebo-controlled clinical trial, we aimed to determine a dose-response effect of galacto-oligosaccharides (GOS) on stool characteristics and fecal...

  • Article
  • Open Access
17 Citations
4,523 Views
16 Pages

Brain tumor (BT) patients have a high incidence of disability due to the effects of the tumor itself or oncological treatment. Despite the incidence of neurological and functional deficits caused by BT, rehabilitation of those patients is not as prop...

of 116